|
Jianping Weng, Vice Minister of Life Sciences and Medicine Department, Executive Dean of Clinical Medical School, Vice President of the First Affiliated Hospital (Anhui Provincial Hospital), President of Bengbu Medical College, Executive Dean of CAS Clinical Research Hospital (Hefei), Director of Endocrinology and Metabolic Diseases Research Institute
University of Science and Technology of China, Mayo Clinic College of Medicine
Area of Focus
Diabetes | Precision Medicine | Diagnosis | Treatment | Pan-Vascular | Lesions | Metabolic | Liver Disease | Big Data | Smart Healthcare |
|
Xiuwu Bian, Chief Physician, Professor
University of Science and Technology of China, Mayo Clinic College of Medicine
Area of Focus
Tumor | Angiogenesis | Anti-Cancer | Drug | Research | Artificial | Intelligence | Pathology | Diagnosis | Stem Cells |
|
Junbo Ge, Chief Physician
University of Science and Technology of China, Mayo Clinic College of Medicine
Area of Focus
Cardiovascular | Coronary | Diagnosis | Treatment | Innovation | Ultrasound | Stents | Intervention | Cell Therapy | Research |
|
Xuqin Jiang, Associate Chief Physician
University of Science and Technology of China, Mayo Clinic College of Medicine
Area of Focus
Pulmonary | Infectious | Diseases | Mechanism | Research | Chronic | Airway | Inflammation | Asthma | Copd |
|
Jiong Shi, Chief Physician, Vice President
University of Science and Technology of China, Mayo Clinic College of Medicine
Area of Focus
Cognition | Neurodegeneration | Alzheimer'S | Biomarkers | Clinical Cohorts | Human-Machine Interaction | Lead Compounds | Diagnosis | Treatment | Interdisciplinary |
|
Da-Long Yin, Chief Physician
University of Science and Technology of China, Mayo Clinic College of Medicine
Area of Focus
Minimally Invasive | Hepatobiliary | Surgery | Pathogenesis | Tumors | Artificial Intelligence | Laparoscopy | Robotics | Diagnosis | Treatment |
|
Lianxin Liu, Professor, Chief Physician
University of Science and Technology of China, Mayo Clinic College of Medicine
Area of Focus
General Surgery | Diagnosis | Treatment | Inflammation | Metabolism | Non-Coding Rna | Immunity | Viruses | Hepatobiliary Tumors | Minimally Invasive |
|
Jia Bei Wang, Researcher, Chief Physician
University of Science and Technology of China, Mayo Clinic College of Medicine
Area of Focus
Pathogenesis | Metabolism | Immune Microenvironment | Targeted Therapy | Drug Resistance | Hepatobiliary Tumors | Cancer Research | Clinical Diagnosis | Basic Research | Oncology |
|
Ji Zhou Wang, Chief Physician, Researcher
University of Science and Technology of China, Mayo Clinic College of Medicine
Area of Focus
Liver | Transplantation | Surgery | Hepatobiliary | Oncology | Research | Clinical | Innovation | Health | Medicine |
|
Ruipeng Song, Associate Chief Physician
University of Science and Technology of China, Mayo Clinic College of Medicine
Area of Focus
Hepatobiliary | Tumor | Development | Mechanisms | Cancer | Liver | Bile Duct | Oncology | Pathogenesis | Research |
